LEXEO THERAPEUTICS INC (LXEO) Stock Income Statement
NASDAQ:LXEO - US52886X1072 - Common Stock
4.73 USD
-0.17 (-3.47%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 650.00K | 1.66M | |||
| Operating Expenses | 123.42M | 106.00M | 68.51M | 61.16M | 52.29M | |||
| Research and Development | 73.68M | N/A | 53.13M | 49.16M | 45.12M | |||
| Selling, General, and Administrative Expenses | 49.74M | 32.00M | 15.38M | 12.00M | 7.17M | |||
| Operating Income | -123.42M | -106.00M | -68.51M | -60.51M | -50.64M | |||
| Interest Income/Expense | 9.29M | N/A | 2.65M | 1.23M | 20.00K | |||
| Other Income/Expense | 2.00K | 8.00M | -530.00K | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -114.17M | -98.00M | -66.39M | -59.28M | -50.62M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Net Income | -114.17M | -98.00M | -66.39M | -59.28M | -50.62M | |||
| EBITDA | -121.38M | -104.00M | -66.67M | -60.24M | -50.63M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.26 | -3.06 | -2.69 | -2.40 | -2.05 | |||
| Non GAAP EPS | -3.26 | -3.08 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -9120.00% | -3049.40% | |||
| Operating Profit Margin | N/A | N/A | N/A | -9309.23% | -3050.60% | |||
All data in USD